文献速递中药与中成药合理使用中医内科

中药对皮肤药物不良反应影响的15年全国性研究

Unveiling the impact of traditional Chinese herbal medicines on cutaneous adverse drug reactions: A landmark 15-year nationwide study.
PubMed 文献 · Phytomedicine · 2024-12-01

结果显示中药与抗生素或NSAIDs联用未显著增加SCARs发生率,但抗生素与NSAIDs联用较单药治疗SCARs频率更高,提示中药在多药方案中安全性较好但仍需监测。

要点

  • 中药与抗生素或NSAIDs联用未显著增加重度皮肤不良反应风险。
  • 抗生素与NSAIDs联用比单药治疗出现更多重度皮肤不良反应。
  • 多药联用尤其是含常规药物时仍需谨慎监测药物安全性。

核心结论

  • 中药与抗生素或NSAIDs联用未显著增加SCARs发生率,提示中药在多药方案中安全性较好,但仍需警惕药物安全监测。

主要发现

  • 中药与抗生素或NSAIDs联用未显著增加SCARs发生率,但中药、抗生素或NSAIDs均占一定比例的皮肤药物不良反应。
  • 抗生素与NSAIDs联用相比单药治疗显示出更高的SCARs发生频率。

临床怎么用

  • 在临床多药联用方案中,可谨慎整合中药,但需对包含常规药物的多药治疗进行仔细监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traditional Chinese herbal medicines (TCMs) have become increasingly integrated into global healthcare systems, often used alongside conventional pharmaceuticals. While TCMs offer therapeutic benefits, their concomitant use with other medications raises concerns over cutaneous adverse drug reactions (CADRs). Despite the widespread use of TCMs, large-scale studies examining their safety in combination with antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs) remain limited. OBJECTIVE: This study aimed to analyze the frequency and severity of CADRs associated with TCMs, focusing on their interactions with antibiotics and NSAIDs in a comprehensive dataset spanning over 15 years in China. METHODS: We retrospectively reviewed clinical data from over 1.8 million patient visits annually between 2007 and 2022. Both mild and severe CADRs (SCARs) associated with TCMs, antibiotics, and NSAIDs were evaluated. RESULTS: While used in combination with antibiotics or NSAIDs, TCMs did not significantly increase the incidence of SCARs, although TCMs, antibiotics, or NSAIDs accounted for a proportion of CADRs. In contrast, the combination of antibiotics with NSAIDs showed a higher frequency of SCARs compared to monotherapy. These results suggest that TCMs have a favorable safety profile in multi-drug regimens, but careful monitoring is essential, particularly in multi-drug therapies involving conventional medications. CONCLUSION: This groundbreaking study provides unprecedented insights into the role of TCMs in CADRs, highlighting their potential for safer integration into multi-drug regimens. Although TCMs did not exacerbate the risk of severe reactions when combined with antibiotics or NSAIDs, vigilance in drug safety protocols remains crucial. These findings support the cautious and well-regulated use of TCMs within broader healthcare frameworks, promoting their safe integration alongside conventional therapies.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. He S, Yang J, Yang F, et al. Unveiling the impact of traditional Chinese herbal medicines on cutaneous adverse drug reactions: A landmark 15-year nationwide study. Phytomedicine. 2024. PMID: 39644761. doi:10.1016/j.phymed.2024.156273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。